Overview
Merry Tetef is a Hematologist Oncology provider in Laguna Hills, California. Dr. Tetef is rated as an Experienced provider by MediFind in the treatment of Lymphofollicular Hyperplasia. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.
Her clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Youram Nassir is a Hematologist Oncology specialist and a Hematologist in Los Angeles, California. Dr. Nassir is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Bone Tumor, Multiple Myeloma, Anemia, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration.
David Park is a Hematologist Oncology provider in Fullerton, California. Dr. Park is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Small Cell Lung Cancer (SCLC), Non-Hodgkin Lymphoma, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Park is currently accepting new patients.
Cedars-Sinai Medical Care Foundation
Kevin Scher is a Hematologist Oncology specialist and a Hematologist in Beverly Hills, California. Dr. Scher is rated as a Distinguished provider by MediFind in the treatment of Lymphofollicular Hyperplasia. His top areas of expertise are Childhood Iron Deficiency Anemia, Colorectal Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Tetef isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Tetef isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Tetef isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Inflammatory Breast CancerDr. Tetef isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Blood ClotsDr. Tetef isExperienced. Learn about Blood Clots.
- Congenital Anti-Plasmin DeficiencyDr. Tetef isExperienced. Learn about Congenital Anti-Plasmin Deficiency.
- DICER1 SyndromeDr. Tetef isExperienced. Learn about DICER1 Syndrome.
- Disseminated Intravascular Coagulation
- EGFR Positive Lung CancerDr. Tetef isExperienced. Learn about EGFR Positive Lung Cancer.